Stroke

被引:922
作者
Hankey, Graeme J. [4 ,1 ,2 ,3 ]
机构
[1] Univ Western Australia, Sch Med & Pharmacol, Perth, WA, Australia
[2] Sir Charles Gairdner Hosp, Dept Neurol, Perth, WA, Australia
[3] WANRI, Perth, WA, Australia
关键词
TRANSIENT ISCHEMIC ATTACK; INDIVIDUAL PATIENT DATA; BLOOD-PRESSURE REDUCTION; EARLY RECURRENT STROKE; PATENT FORAMEN OVALE; INTRACEREBRAL HEMORRHAGE; ANTIPLATELET THERAPY; ATRIAL-FIBRILLATION; GLOBAL BURDEN; MINOR STROKE;
D O I
10.1016/S0140-6736(16)30962-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the past decade, the definition of stroke has been revised and major advances have been made for its treatment and prevention. For acute ischaemic stroke, the addition of endovascular thrombectomy of proximal large artery occlusion to intravenous alteplase increases functional independence for a further fifth of patients. The benefits of aspirin in preventing early recurrent ischaemic stroke are greater than previously recognised. Other strategies to prevent recurrent stroke now include direct oral anticoagulants as an alternative to warfarin for atrial fibrillation, and carotid stenting as an alternative to endarterectomy for symptomatic carotid stenosis. For acute intracerebral haemorrhage, trials are ongoing to assess the effectiveness of acute blood pressure lowering, haemostatic therapy, minimally invasive surgery, anti-infl ammation therapy, and neuroprotection methods. Pharmacological and stem-cell therapies promise to facilitate brain regeneration, rehabilitation, and functional recovery. Despite declining stroke mortality rates, the global burden of stroke is increasing. A more comprehensive approach to primary prevention of stroke is required that targets people at all levels of risk and is integrated with prevention strategies for other diseases that share common risk factors.
引用
收藏
页码:641 / 654
页数:14
相关论文
共 142 条
  • [1] CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL
    ADAMS, HP
    BENDIXEN, BH
    KAPPELLE, LJ
    BILLER, J
    LOVE, BB
    GORDON, DL
    MARSH, EE
    KASE, CS
    WOLF, PA
    BABIKIAN, VL
    LICATAGEHR, EE
    ALLEN, N
    BRASS, LM
    FAYAD, PB
    PAVALKIS, FJ
    WEINBERGER, JM
    TUHRIM, S
    RUDOLPH, SH
    HOROWITZ, DR
    BITTON, A
    MOHR, JP
    SACCO, RL
    CLAVIJO, M
    ROSENBAUM, DM
    SPARR, SA
    KATZ, P
    KLONOWSKI, E
    CULEBRAS, A
    CAREY, G
    MARTIR, NI
    FICARRA, C
    HOGAN, EL
    CARTER, T
    GURECKI, P
    MUNTZ, BK
    RAMIREZLASSEPAS, M
    TULLOCH, JW
    QUINONES, MR
    MENDEZ, M
    ZHANG, SM
    ALA, T
    JOHNSTON, KC
    ANDERSON, DC
    TARREL, RM
    NANCE, MA
    BUDLIE, SR
    DIERICH, M
    HELGASON, CM
    HIER, DB
    SHAPIRO, RA
    [J]. STROKE, 1993, 24 (01) : 35 - 41
  • [2] Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial
    Albers, Gregory W.
    von Kummer, Ruediger
    Truelsen, Thomas
    Jensen, Jens-Kristian S.
    Ravn, Gabriela M.
    Gronning, Bjorn A.
    Chabriat, Hugues
    Chang, Ku-Chou
    Davalos, Antonio E.
    Ford, Gary A.
    Grotta, James
    Kaste, Markku
    Schwamm, Lee H.
    Shuaib, Ashfaq
    [J]. LANCET NEUROLOGY, 2015, 14 (06) : 575 - 584
  • [3] The ASCOD Phenotyping of Ischemic Stroke (Updated ASCO Phenotyping)
    Amarenco, P.
    Bogousslavsky, J.
    Caplan, R.
    Donnan, G. A.
    Wolf, M. E.
    Hennerici, M. G.
    [J]. CEREBROVASCULAR DISEASES, 2013, 36 (01) : 1 - 5
  • [4] One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke
    Amarenco, Pierre
    Lavallee, Philippa C.
    Labreuche, Julien
    Albers, Gregory W.
    Bornstein, Natan M.
    Canhao, Patricia
    Caplan, Louis R.
    Donnan, Geoffrey A.
    Ferro, Jose M.
    Hennerici, Michael G.
    Molina, Carlos
    Rothwell, Peter M.
    Sissani, Leila
    Skoloudik, David
    Steg, Philippe Gabriel
    Touboul, Pierre-Jean
    Uchiyama, Shinichiro
    Vicaut, Eric
    Wong, Lawrence K. S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (16) : 1533 - 1542
  • [5] Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
    Amarenco, Pierre
    Labreuche, Julien
    [J]. LANCET NEUROLOGY, 2009, 8 (05) : 453 - 463
  • [6] Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke
    Anderson, C. S.
    Robinson, T.
    Lindley, R. I.
    Arima, H.
    Lavados, P. M.
    Lee, T. -H.
    Broderick, J. P.
    Chen, X.
    Chen, G.
    Sharma, V. K.
    Kim, J. S.
    Thang, N. H.
    Cao, Y.
    Parsons, M. W.
    Levi, C.
    Huang, Y.
    Olavarria, V. V.
    Demchuk, A. M.
    Bath, P. M.
    Donnan, G. A.
    Martins, S.
    Pontes-Neto, O. M.
    Silva, F.
    Ricci, S.
    Roffe, C.
    Pandian, J.
    Billot, L.
    Woodward, M.
    Li, Q.
    Wang, X.
    Wang, J.
    Chalmers, J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (24) : 2313 - 2323
  • [7] [Anonymous], 2001, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000197, 10.1002/14651858.Cd000197]
  • [8] [Anonymous], LANCET
  • [9] Use of PER977 to Reverse the Anticoagulant Effect of Edoxaban
    Ansell, Jack E.
    Bakhru, Sasha H.
    Laulicht, Bryan E.
    Steiner, Solomon S.
    Grosso, Michael
    Brown, Karen
    Dishy, Victor
    Noveck, Robert J.
    Costin, James C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (22) : 2141 - 2142
  • [10] Who, when, and how to reverse non-vitamin K oral anticoagulants
    Aronis, Konstantinos N.
    Hylek, Elaine M.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2016, 41 (02) : 253 - 272